Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L King

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Ebiomedicine|May 23, 2022
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residentsDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Aging Clinical and Experimental Research|March 7, 2025
COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residentsOladayo A Oyebanji, Anna Yin, Nicholas Sundheimer, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
Aging Clinical and Experimental Research|October 15, 2021
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?Oladayo A Oyebanji, Brigid Wilson, Debbie Keresztesy, et al.
Plos Medicine|September 14, 2012
Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control studyAnna Rosanas-Urgell, Enmoore Lin, Laurens Manning, et al.
The Lancet. Infectious Diseases|May 9, 2022
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trialMoses Laman, Livingstone Tavul, Stephan Karl, et al.
Journal of the American Geriatrics Society|December 14, 2025
Immunologic Evaluation of First and Second Doses of SARS-CoV-2 XBB.1.5 and the KP.2 Monovalent Booster Vaccines in Nursing Home ResidentsOlajide J Olagunju, Oladayo A Oyebanji, Debbie Keresztesy, et al.
Iscience|May 7, 2026
Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccinationJeeda Ismail, Banumathi Tamilselvan, Michael Rubsamen, et al.
Clinical and Vaccine Immunology : CVI|December 15, 2015
Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth CohortArlene E Dent, Indu Malhotra, Xuelie Wang, et al.
The American Journal of Tropical Medicine and Hygiene|October 13, 2022
Enhancing Malaria Research, Surveillance, and Control in Endemic Areas of Kenya and EthiopiaJohn I Githure, Delenasaw Yewhalaw, Harrysone Atieli, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Ebiomedicine|May 23, 2022
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residentsDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Aging Clinical and Experimental Research|March 7, 2025
COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residentsOladayo A Oyebanji, Anna Yin, Nicholas Sundheimer, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
Aging Clinical and Experimental Research|October 15, 2021
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?Oladayo A Oyebanji, Brigid Wilson, Debbie Keresztesy, et al.
Plos Medicine|September 14, 2012
Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control studyAnna Rosanas-Urgell, Enmoore Lin, Laurens Manning, et al.
The Lancet. Infectious Diseases|May 9, 2022
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trialMoses Laman, Livingstone Tavul, Stephan Karl, et al.
Journal of the American Geriatrics Society|December 14, 2025
Immunologic Evaluation of First and Second Doses of SARS-CoV-2 XBB.1.5 and the KP.2 Monovalent Booster Vaccines in Nursing Home ResidentsOlajide J Olagunju, Oladayo A Oyebanji, Debbie Keresztesy, et al.
Iscience|May 7, 2026
Single-cell transcriptomics reveal altered B cell responses and T cell senescence in geriatric non-responders to COVID-19 mRNA vaccinationJeeda Ismail, Banumathi Tamilselvan, Michael Rubsamen, et al.
Clinical and Vaccine Immunology : CVI|December 15, 2015
Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth CohortArlene E Dent, Indu Malhotra, Xuelie Wang, et al.
The American Journal of Tropical Medicine and Hygiene|October 13, 2022
Enhancing Malaria Research, Surveillance, and Control in Endemic Areas of Kenya and EthiopiaJohn I Githure, Delenasaw Yewhalaw, Harrysone Atieli, et al.
Pageof 18